Bioactive compounds: Safety and efficacy
详细信息 查看全文
- 作者：Hans-Konrad Biesalski ; Lars Ove Dragsted ; Ibrahim Elmadfa ; Rolf Grossklaus ; Michael Mü ; ller ; Dieter Schrenk ; Paul Walter ; Peter Weber
- 关键词：Biomarker ; Bioactive constituents ; Nutraceuticals ; Health effect ; Xenobiotics ; Bioavailability ; Intake ; Phytochemicals
- 刊名：Nutrition
- 出版年：2009
- 出版时间：November-December 2009
- 年：2009
- 卷：25
- 期：11-12
- 页码：1206-1211
- 全文大小：232 K
文摘
The efficacy and safety of bioactive compounds depend on a few known and unknown parameters. What is a physiologic dose and how can that dose be defined in cases of bioactive compounds with a poor knowledge of supply and distribution? What safety sets are needed? How can individual aspects such as polymorphisms or differences in absorption be considered? A group of experts tried to answer these and related questions during the 23rd Hohenheim Consensus Meeting at the University of Hohenheim in Stuttgart.